Auteur T. ROJAS ROJAS

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO project

T. ROJAS ROJAS ; V. DI BEO ; J. DELORME ; T. BARRÉ ; P. MATHURIN ; C. PROTOPOPESCU ; F. BAILLY ; M. COSTE ; N. AUTHIER ; M. P. CARRIERI ; B. ROLLAND ; F. MARCELLIN | 2019
Dans International Journal of Drug Policy (Vol.72, October 2019) Article : Périodique

Background: In the era of direct-acting antivirals (DAA) for the treatment of hepatitis C virus (HCV) infection, HCV treatment uptake remains insufficiently documented in key populations such as people with opioid dependence. Access to opioid ag[...]

Plus d'info

Ajouter à la sélection

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS-FANTASIO study)

T. BARRÉ ; F. MARCELLIN ; V. DI BEO ; J. DELORME ; T. ROJAS ROJAS ; P. MATHURIN ; C. PROTOPOPESCU ; F. BAILLY ; M. COSTE ; N. AUTHIER ; M. P. CARRIERI ; B. ROLLAND | 2020
Dans Addiction (Vol.115, n°3, March 2020) Article : Périodique

BACKGROUND AND AIMS: Although people who inject drugs (PWID) are the core at-risk population in the hepatitis C virus (HCV) epidemic in industrialized countries, few initiate treatment. Alcohol use disorder (AUD), common within this population, [...]

Plus d'info

Ajouter à la sélection

Lien externe